Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for June 2009
June 1, 2009
June 2, 2009
- Pfizer Discontinues SUN 1094 Trial of Sunitinib plus Paclitaxel in Advanced Breast Cancer
- Genzyme Completes Transaction with Bayer HealthCare
- TorreyPines Therapeutics Announces its Board of Directors' Approval of Plan of Liquidation and Dissolution
- FDA Warnings About Antidepressants Associated With Lasting, Unintended Changes in Diagnosis and Treatment
- Drug Industry Marketing Direct to Consumers and Doctors May Lead to Prescription Overuse
- PharmaLive.com Launches New Report on DTC Ad Spending
- Concert Pharmaceuticals and GlaxoSmithKline Form Alliance to Develop Novel Deuterium Modified Drugs
- Bio-Imaging Technologies and etrials Worldwide Merger Agreement Terminated
June 3, 2009
- Advaxis Receives FDA Response to Orphan Drug Filing
- FDA Forms Transparency Task Force
- Almotriptan (Axert/Almogran) Approved by the FDA for the Treatment of Migraine in Adolescents
- Pfizer Announces Completion Of European Debt Offering
- FDA MedWatch - Propylthiouracil (PTU) associated with risk of serious liver injury, including liver failure and death
- Genmab Announces Partial Clinical Hold on Zalutumumab Studies
June 4, 2009
- Adolor Corporation Announces Staff Reductions and Restructuring
- FDA Warns About Serious Liver Injury Associated With Anti-Thyroid Drug
- Abbott and AstraZeneca Extend Relationship to Include Co-Promotion of Trilipix (fenofibric acid)
- Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598
- Johnson & Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs
June 5, 2009
June 8, 2009
- Aileron Therapeutics Closes $40 Million Series D Financing
- Jean-Philippe Santoni Appointed Senior Vice President, Industrial Development and Innovation
- EU-wide Recall of Raptiva (efalizumab) to be Initiated
- Sanofi-aventis to Purchase Diabel Manufacturing Facility in Frankfurt to Strengthen Insulin Production Capacities
- Alder Biopharmaceuticals Announces Expanded Collaboration With Schering-Plough
- Commonwealth Biotechnologies, Inc. Announces Agreement to Acquire GL Biochem (Shanghai) Ltd
June 9, 2009
- CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
- House Committee on Energy and Commerce Chairman Waxman Writes President Obama Regarding Generic Biologics
- Progenics Provides Update on Hepatitis C Program
- Merck & Co.: Corporations Need to Tackle Global Corruption as Strategic CSR Effort
- GSK and Shenzhen Neptunus Create New Alliance to Develop and Manufacture Influenza Vaccines in China
- NAACP & Nine Class Reps File Motion for Class Certification Against Eli Lilly in Pervasive Discrimination Case
June 10, 2009
June 11, 2009
- Xenon Enters Cardiovascular Disease Collaboration With Merck & Co., Inc.
- FTC Releases Report on ?Follow-on Biologic Drug Competition?
- Neuromed Announces that Merck & Co., Inc. Terminates Research Collaboration and License Agreement for Compounds Targeting N-Type Calcium Channels
- TNS Media Intelligence Reports U.S. Advertising Expenditures Declined 14.2 Percent First Quarter 2009
- Commonwealth Biotechnologies, Inc. Provides Market Update on Contemplated Acquisition of GL Biochem
June 12, 2009
- Cumberland Pharmaceuticals Announces FDA Approval of Caldolor
- ImmunoGen, Inc. Elects to Discontinue Further Internal Development of Its IMGN242 Compound
- Oscient Pharmaceuticals Discontinues Sales Force Promotion for Antara and Factive
- Genaera Corporation Board of Directors Dissolves Corporation and Forms Liquidating Trust
- 61% of American Adults Look Online for Health Information
June 15, 2009
- Boehringer Ingelheim and Vitae Pharmaceuticals Announce a Major Collaboration to Research and Develop Novel Treatments for Alzheimer`s disease
- Synta and GSK End Elesclomol Collaboration Agreement
- Dr. Reddy's Announces Strategic Alliance with GSK for Emerging Markets
June 16, 2009
- FDA Issues Safety Communication about an Ongoing Review of Stimulant Medications Used in Children with ADHD
- FDA Warns Web Sites Against Marketing Fraudulent H1N1 Flu Virus Claims
- Eli Lilly and Company Announces New Drug Discovery Initiative
- Genzyme Temporarily Interrupts Production at Allston Plant
- Adimab Launches Novel Antibody Discovery Platform and Announces Discovery Programs with Merck and Roche
June 17, 2009
- Watson to Acquire Arrow Group
- Biogen Idec Announces Conclusion of Arbitration with Genentech
- Health Care Reform May Force U.S. Pharmaceutical Companies to Overhaul Sales Strategies, Says New Report From ZS Associates and eyeforpharma
June 18, 2009
- Manhattan Pharmaceuticals Provides Corporate Update on Hedrin and Management Restructuring
- Cefepime (marketed as Maxipime) Update of Ongoing Safety Review
- S&P: Europe's Pharmaceutical Firms Buck The Recession With Strong Sales Growth In 2009, Says Report
June 19, 2009
- FDA Grants The Medicines Company Pediatric Exclusivity for Angiomax
- Hospira Receives Favorable Court Decision on Eloxatin
- Pharmaceutical Company Manager Sentenced For Off-Label Marketing
June 22, 2009
- Merck & Co., Inc. Statement on Medicare Part D Assistance
- Vical Receives Milestone Payment From Merck & Co., Inc.
- NeurogesX and Astellas Enter Commercialization Agreement for Qutenza
- Merck and Schering-Plough Receive Request for Additional Information from FTC Regarding Proposed Merger
- PhRMA Statement on the Health Care Reform Agreement
- Biogen Idec Announces First Patient Enrolled in the Global Phase III Study of PEGylated Interferon Beta-1a for Relapsing Multiple Sclerosis
- KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10-K
June 23, 2009
- Merck Prices $4.25 Billion Debt Offering
- Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
- Cell Genesys Announces Tender Offer Results While Continuing to Pursue Strategic Alternatives
- Deductibility of Prescription Drug Ads May Be Under Threat
- GSK and Chroma Therapeutics Form Alliance to Develop Novel Macrophage-Targeted Drugs
- Mass. AG Martha Coakley?s Office Files Complaint Against Drug Manufacturer Wyeth
- PharmaLive.com Launches New Pipeline Report
June 24, 2009
- Medifacts Acquires Spacelabs Healthcare Clinical Trials Services Division
- Takeda Announces Completion of Tender Offer for All Outstanding Shares of IDM Pharma, Inc.
- Faes Farma and Pfizer Are Negotiating Semi Exclusive Licences for Bilastine in Certain Countries
- Teva Pharmaceuticals Issues Statement in Response to Federal Trade Commission Claims on Patent Settlements
June 25, 2009
- Baxter to Acquire Continuous Renal Replacement Therapy Business from Edwards Lifesciences
- Novo Growth Equity Expands Team, and Will Invest Up to $200M Per Year
- Sen. Grassley Seeks Information About Medical School Policies for Disclosure of Financial Ties
- Uluru Discussions to Acquire York Pharma, plc Are Currently Terminated
- ONGLYZA (Saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes
June 26, 2009
- U.S. Marshals Seize Drug Products Manufactured by Caraco Pharmaceutical Laboratories Ltd.
- Caraco Pharmaceutical Laboratories, Ltd. Updates on Financial Position
- CHMP Issue Opinions
- Announcement of Establishment of a Holding Company in the U.S.
- Novo Nordisk Reaches Settlement With the Danish Authorities Regarding Oil-for-Food Activities
- Boston Scientific Announces Retirement of Jim Tobin and Appointment of Ray Elliott as New President and CEO
June 28, 2009
- Sanofi-aventis Stands Behind the Safety of Lantus
- Jerini AG (DE) - Ad hoc: Jerini AG to Wind Down its Preclinical Programs
June 29, 2009
- A Side Effect of Michael Jackson’s Tragic Death – Consumer Health Education
- Bayer Schering Pharma Extends Research Portfolio in the Field of Cancer-Related Targets
- Simponi (Golimumab) Receives Positive Opinion from Chmp for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
- ChemGenex to Seek Voluntary De-Listing From NASDAQ and to Restructure Board to Reflect Compliance Needs
- Christian Lajoux Appointed President for sanofi-aventis in France
- UCB Brings Neupro Back to All Patients in Europe
- FDA Sends Romark Laboratories Warning Letter About Statements on Alinia Sales
- FDA Reviews Mailer from Millennium Pharmaceuticals for Velcade
June 30, 2009
- Sanofi-Aventis Presents New R&D Model Project to Boost Innovation
- Centocor Ortho Biotech Inc. Awarded $1.67 Billion Patent Jury Verdict from Abbott Laboratories
- BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement
- UCB (BE) - UCB and Biogen Idec Discontinue Phase II Clinical Trial of CDP323
- Collegium Pharmaceutical Announces the Sale of AllerNaze to Lupin
- Pfizer Discontinues Phase 3 Trial of Sutent® in Metastatic Colorectal Cancer
